ProfileGDS4284 / 234868_s_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 35% 46% 40% 35% 27% 13% 6% 25% 24% 30% 6% 21% 17% 11% 24% 23% 12% 24% 34% 12% 39% 41% 12% 12% 14% 17% 5% 43% 27% 22% 25% 9% 36% 34% 13% 15% 43% 23% 13% 16% 14% 14% 9% 15% 28% 14% 25% 9% 15% 9% 43% 2% 7% 24% 7% 39% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control94.755135
GSM687648Patient 402 control168.05246
GSM687653Patient 403 control121.34740
GSM687658Patient 404 control103.13335
GSM687663Patient 411 control74.769127
GSM687668Patient 422 control22.199513
GSM687673Patient 424 control12.81116
GSM687678Patient 425 control64.651425
GSM687683Patient 427 control59.607324
GSM687688Patient 428 control78.43930
GSM687695Patient 441 control21.89596
GSM687699Patient 443 control50.320621
GSM687704Patient 444 control31.373917
GSM687707Patient 448 control24.07911
GSM687712Patient 449 control54.352824
GSM687719Patient 450 control62.421823
GSM687724Patient 451 control24.294812
GSM687728Patient 452 control62.294524
GSM687646Patient 401 treated 24h95.282834
GSM687649Patient 402 treated 24h17.682712
GSM687665Patient 411 treated 24h137.50839
GSM687651Patient 402 treated 4 weeks150.36641
GSM687667Patient 411 treated 4 weeks21.599512
GSM687670Patient 422 treated 24h21.743212
GSM687671Patient 422 treated 4 weeks22.739514
GSM687654Patient 403 treated 24h27.826417
GSM687675Patient 424 treated 24h12.04265
GSM687685Patient 427 treated 24h156.50243
GSM687656Patient 403 treated 4 weeks58.515227
GSM687677Patient 424 treated 4 weeks46.32222
GSM687687Patient 427 treated 4 weeks51.832925
GSM687692Patient 428 treated 4h15.21719
GSM687716Patient 449 treated 4h107.89536
GSM687722Patient 450 treated 4h115.25634
GSM687680Patient 425 treated 24h22.750113
GSM687690Patient 428 treated 24h24.741315
GSM687700Patient 443 treated 24h224.4943
GSM687705Patient 444 treated 24h45.850723
GSM687714Patient 449 treated 24h20.651913
GSM687721Patient 450 treated 24h35.95416
GSM687682Patient 425 treated 4 weeks23.267714
GSM687694Patient 428 treated 4 weeks21.734614
GSM687702Patient 443 treated 4 weeks17.11739
GSM687718Patient 449 treated 4 weeks28.742215
GSM687723Patient 450 treated 4 weeks75.532828
GSM687661Patient 404 treated 4h25.980214
GSM687710Patient 448 treated 4h59.07125
GSM687726Patient 451 treated 4h18.80729
GSM687730Patient 452 treated 4h60.915115
GSM687660Patient 404 treated 24h23.78429
GSM687697Patient 441 treated 24h207.70443
GSM687709Patient 448 treated 24h6.859522
GSM687725Patient 451 treated 24h16.3757
GSM687729Patient 452 treated 24h81.620924
GSM687727Patient 451 treated 4 weeks15.74757
GSM687731Patient 452 treated 4 weeks144.37239